BioCentury
ARTICLE | Clinical News

Genentech regulatory update

March 14, 1994 8:00 AM UTC

Genentech Inc. (GNE) GNE (South San Francisco) received FDA approval to market Nutropin human growth hormone to treat growth failure in children with inadequate levels of the natural hormone. This is...